Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

2016294 citationsJournal Article

Authors

Industry, innovation and infrastructure

Published in: The Lancet Respiratory Medicine

Volume 5, Issue 1, pp. 42-50

Field-Weighted Citation Impact: 30.04